Mr Steven McFarlane

  • Research Project Support (Centre for Virus Research)

telephone: 01413307101
email: Steven.McFarlane@glasgow.ac.uk

Research interests

CVR logo 

Member of the Boutell group.


Publications

List by: Type | Date

Jump to: 2019 | 2018 | 2016 | 2011
Number of items: 6.

2019

Charman, M. et al. (2019) Constitutive TRIM22 expression within the respiratory tract identifies tissue-specific and cell-type dependent intrinsic immune barriers to influenza A virus infection. bioRxiv, (doi:10.1101/679159) (Early Online Publication)

McFarlane, S. et al. (2019) The histone chaperone HIRA promotes the induction of host innate immune defences in response to HSV-1 infection. PLoS Pathogens, 15(3), e1007667. (doi:10.1371/journal.ppat.1007667) (PMID:30901352) (PMCID:PMC6472835)

2018

Alandijany, T., Roberts, A. P.E., Conn, K. L., Loney, C., McFarlane, S., Orr, A. and Boutell, C. (2018) Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection. PLoS Pathogens, 14(1), e1006769. (doi:10.1371/journal.ppat.1006769) (PMID:29309427) (PMCID:PMC5757968)

2016

Brown, J. R., Conn, K. L., Wasson, P., Charman, M., Tong, L., Grant, K., McFarlane, S. and Boutell, C. (2016) The SUMO Ligase Protein Inhibitor of Activated STAT 1 (PIAS1) is a constituent PML-NB protein that contributes to the intrinsic antiviral immune response to herpes simplex virus 1 (HSV-1). Journal of Virology, 90, 13. (doi:10.1128/JVI.00426-16) (PMID:27099310) (PMCID:PMC4907222)

Conn, K. L., Wasson, P., McFarlane, S., Tong, L., Brown, J. R., Grant, K. G., Domingues, P. and Boutell, C. (2016) A novel role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the restriction of herpes simplex virus 1 (HSV-1) by the cellular intrinsic antiviral immune response. Journal of Virology, 90(9), pp. 4807-4826. (doi:10.1128/JVI.03055-15) (PMID:26937035)

2011

Boutell, C. , Cuchet, D., Vanni, E. , Orr, A., Glass, M., McFarlane, S. and Everett, R.D. (2011) A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathogens, 7(9), e1002245. (doi:10.1371/journal.ppat.1002245) (PMID:21949651) (PMCID:PMC3174244)

This list was generated on Fri Oct 18 22:37:09 2019 BST.
Jump to: Articles
Number of items: 6.

Articles

Charman, M. et al. (2019) Constitutive TRIM22 expression within the respiratory tract identifies tissue-specific and cell-type dependent intrinsic immune barriers to influenza A virus infection. bioRxiv, (doi:10.1101/679159) (Early Online Publication)

McFarlane, S. et al. (2019) The histone chaperone HIRA promotes the induction of host innate immune defences in response to HSV-1 infection. PLoS Pathogens, 15(3), e1007667. (doi:10.1371/journal.ppat.1007667) (PMID:30901352) (PMCID:PMC6472835)

Alandijany, T., Roberts, A. P.E., Conn, K. L., Loney, C., McFarlane, S., Orr, A. and Boutell, C. (2018) Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection. PLoS Pathogens, 14(1), e1006769. (doi:10.1371/journal.ppat.1006769) (PMID:29309427) (PMCID:PMC5757968)

Brown, J. R., Conn, K. L., Wasson, P., Charman, M., Tong, L., Grant, K., McFarlane, S. and Boutell, C. (2016) The SUMO Ligase Protein Inhibitor of Activated STAT 1 (PIAS1) is a constituent PML-NB protein that contributes to the intrinsic antiviral immune response to herpes simplex virus 1 (HSV-1). Journal of Virology, 90, 13. (doi:10.1128/JVI.00426-16) (PMID:27099310) (PMCID:PMC4907222)

Conn, K. L., Wasson, P., McFarlane, S., Tong, L., Brown, J. R., Grant, K. G., Domingues, P. and Boutell, C. (2016) A novel role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the restriction of herpes simplex virus 1 (HSV-1) by the cellular intrinsic antiviral immune response. Journal of Virology, 90(9), pp. 4807-4826. (doi:10.1128/JVI.03055-15) (PMID:26937035)

Boutell, C. , Cuchet, D., Vanni, E. , Orr, A., Glass, M., McFarlane, S. and Everett, R.D. (2011) A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathogens, 7(9), e1002245. (doi:10.1371/journal.ppat.1002245) (PMID:21949651) (PMCID:PMC3174244)

This list was generated on Fri Oct 18 22:37:09 2019 BST.